Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Textual)

v3.10.0.1
Commitments and Contingencies (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 14, 2014
Dec. 31, 2015
Sep. 30, 2018
Sep. 30, 2017
Jun. 30, 2015
Apr. 30, 2013
Commitments and Contingencies [Line Items]            
Research and Development Expense, Total     $ 1,124,000 $ 985,000    
Royalty Guarantees, Commitments, Amount     $ 200,000      
Long Term Purchase Commitment Expire Date     Dec. 31, 2015      
Operating Leases, Rent Expense     $ 2,100,000      
Commitments [Member]            
Commitments and Contingencies [Line Items]            
Research Services Agreements Value Fulfilling Commitment   $ 3,000,000        
Royalty Guarantees, Commitments, Amount   $ 3,000,000        
License Cost $ 30,627          
Initial license fee 20,000          
Settlement Agreement [Member]            
Commitments and Contingencies [Line Items]            
Prepaid Expense           $ 1,000,000
Amended Agreement [Member]            
Commitments and Contingencies [Line Items]            
Research and Development Expense, Total         $ 2,100,000  
Second Eastern Affilate [Member]            
Commitments and Contingencies [Line Items]            
Research and Development Expense, Total       184,000    
Minimum [Member] | Commitments [Member]            
Commitments and Contingencies [Line Items]            
License Cost 25,000          
Maximum [Member] | Commitments [Member]            
Commitments and Contingencies [Line Items]            
License Cost $ 150,000          
Fraunhofer [Member]            
Commitments and Contingencies [Line Items]            
Royalty Guarantees, Commitments, Amount     $ 4,000,000      
Other Commitments, Description     the 2013 Settlement Agreement provided that, for a period of up to 15 years, the Company would pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch™ or iBioModulator™ technology and ten percent (10%) of all receipts derived by the Company from licensing those technologies to third parties.      
iBio CDMO LLC [Member] | Second Eastern Affilate [Member]            
Commitments and Contingencies [Line Items]            
Operating Leases, Rent Expense     $ 12,000 $ 15,000